Articles by Editor

Pharmacy benefit manager’s new brand pillars leverage strengths to better serve their partners and clients.

MILWAUKEE, September 13, 2023 (Newswire.com)
–
Serve You Rx, a pharmacy benefit management (PBM) company focused on service and flexibility, unveiled its new branding today. Flexibility, quality, and a client-centered approach are central to its transformation. These brand pillars reflect the company’s evolved approach to the market and underscore a paradigm shift in thinking. 

The PBM industry is undergoing significant transformations, driven by the rising complexity and cost of prescription drugs, decreased satisfaction with PBM providers, and an increased focus on transparency. With its dedication to quality, adaptability, and client-centricity, Serve You Rx is poised to deliver innovative solutions that address these challenges. 

Ted Boylan, PharmD, President of Serve You Rx, believes the rebranding project supports the new phase of growth and innovation the company is experiencing. “Guided by the pillars of flexibility, quality, and client-centricity, we are developing and delivering what our customers demand — impactful programs and partnerships that exceed cost management and service expectations,” Boylan said.

For 36 years, Serve You Rx has built a successful business serving small- and mid-market self-insured groups. Today, with clients nationwide, Serve You Rx serves a diverse range of organizations, including commercial employers, government entities, labor unions, tribal nations, hospitals and health systems, coalitions, and captives. 

“In a time when the PBM sector is grappling with dissatisfaction and calls for greater transparency, Serve You Rx is stepping up to redefine what a PBM partner focused on you can do,” said Serve You Rx CEO Justin Jasniewski. “This rebrand isn’t a mere aesthetic change; it’s our renewed vow to deliver unparalleled service and value to our clients.”

For more information about the company and its services, visit ServeYouRx.com. 

About Serve You Rx  
Serve You Rx is a full-service pharmacy benefit manager (PBM) with unquestionable flexibility and an unwavering commitment to doing what’s best for its clients. With a fervent focus on those it serves, including insurance brokers, consultants, third-party administrators, and their clients, Serve You Rx delivers exceptional service and tailored, cost-effective benefit solutions. Independent and privately held for over 36 years, Serve You Rx can implement new groups in 30 days or less and say “yes” to a wide variety of viable solutions. Known for its adaptability, quality, and client-centricity, Serve You Rx aims to be a benchmark for better client service.

Contact Information:

Nancy Fleming

Marketing Director

[email protected]

414-410-8164

Original Source:

Serve You Rx Transforms Pharmacy Benefit Management With New Client-Centered Branding Strategy

The post Serve You Rx Transforms Pharmacy Benefit Management With New Client-Centered Branding Strategy appeared first on AESTHETIC NEWS.

ANN ARBOR, Mich., September 13, 2023 (Newswire.com)
–
LanguageLine Solutions, the world leader in language access and interpretation services, has annou…

The post LanguageLine Solutions Integrates With VidaTalk, Pioneering Seamless Language Access for Healthcare Patients and Providers appeared first on AESTHETIC NEWS.

Leveraging Product Security Hub’s platform, Apraciti Announces the Launch of the 2nd Annual Medical Device Cybersecurity Industry Benchmarking Assessment and Encourages all Medical Device Manufacturers to Participate

HADDONFIELD, N.J., September 12, 2023 (Newswire.com)
–
Apraciti, LLC, a leading provider of medical device cybersecurity services, has today announced the launch of the 2^nd Annual Medical Device Cybersecurity Industry Benchmarking Assessment in Partnership with the Medical Device Innovation Consortium. The complimentary assessment is hosted by Product Security Hub, a platform and workplace for medical device cybersecurity, built for medical device manufacturers. 

“One of the goals we had in developing the original Joint Security Plan (“JSP”) with the Healthcare and Public Health Sector Coordinating Council was to provide medical device manufacturers with information and tools to help them build and mature their product security programs to further protect patient safety. With the release of the 2^nd Annual Assessment, we are continuing to support that mission and help drive the industry forward in such a critical domain,” said Colin Morgan, Managing Director of Apraciti, LLC.   

Companies who take part in the survey will gain an understanding of their overall maturity rating, based on the JSP, as well as security domain ratings and details of how each question was answered. This will provide them the opportunity to assess their current position and determine areas for improvement.

“It’s common for Product Security leaders to be asked how their program compares to their peers in the industry, or what aspects of the program should be prioritized to continuously improve. Participating in this assessment is a great starting point to help begin to answer these important questions,” said Morgan.

The assessment can be found by navigating to the Product Security Hub Login Instructions page (https://productsecurityhub.com/product-security-hub-login-instructions/).

About Apraciti, LLC

Apraciti, LLC specializes in providing comprehensive cybersecurity services tailored specifically for medical device manufacturers. With a dedicated focus on product security, Apraciti offers services and expertise to help fortify the security of products and programs. Apraciti’s mission is to ensure the cybersafety, reliability, and compliance of medical devices, thereby safeguarding patient safety and building trust in the healthcare industry. Please visit us at https://www.apraciti.com or follow on LinkedIn https://www.linkedin.com/company/apraciti.

About Product Security Hub, LLC

Product Security Hub offers multiple solutions for medical device manufacturers to help manage cybersecurity across their program and products, such as ProdSecMaturity and ProdSecDesigner. With ProdSecMaturity, companies can assess the maturity of their company operations and processes, identify and plan goals, prioritize activities, and mature their cybersecurity program. Companies can also assess their organization’s maturity on industry frameworks such as the FDA Pre-Market Cybersecurity Draft Guidance, FDA Post-Market Management of Cybersecurity in Medical Devices, EU MDCG Cybersecurity for Devices Regulatory Requirements and more. ProdSecDesigner enables design and development teams to inventory products, document components, analyze threats, manage requirements, and review residual risks.  For more information, please visit https://www.productsecurityhub.com or follow on LinkedIn https://www.linkedin.com/company/productsecurityhub. 

Contact Information:

Colin Morgan

Managing Director

[email protected]

215-613-9900

Original Source:

Apraciti Announces the Launch of the 2nd Annual Medical Device Cybersecurity Industry Benchmarking Assessment in Partnership With the Medical Device Innovation Consortium

The post Apraciti Announces the Launch of the 2nd Annual Medical Device Cybersecurity Industry Benchmarking Assessment in Partnership With the Medical Device Innovation Consortium appeared first on AESTHETIC NEWS.

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode
as method to target treatment

…

The post CARDIO inCode Study Results Presented at ESC Annual Meeting appeared first on AESTHETIC NEWS.

CEO and Founder of Neurovations Dr. Eric Grigsby Celebrates Three Decades of Innovation in Chronic Pain Management at 30th Napa Pain Conference

Nap…

The post 30 Years of Groundbreaking Medical Education Features Award-Winning Speakers appeared first on AESTHETIC NEWS.

Conservative care private practice owners can leverage Breakthrough’s exclusive marketing campaigns to promote Enovis™ Corporation’s innovative therapeutic technologies directly to patients.

LOS ANGELES, September 11, 2023 (Newswire.com)
–
Breakthrough, a leader in conservative care marketing solutions, together with Enovis™ Corporation, a pioneer in innovative rehabilitation technologies and parent company to Chattanooga^Ⓡ & LightForce^Ⓡ is excited to announce their official partnership. 

Enovis™ offers clinically differentiated rehabilitation technologies that help to enhance patient outcomes; Breakthrough offers data-driven healthcare marketing solutions. Breakthrough’s Patient Demand marketing software now offers multiple options for turnkey, data-driven campaigns designed to promote Chattanooga® & LightForce® technology directly to patients.

Through this new partnership, conservative care practice owners can reach more patients and overcome declining reimbursements by promoting high-tech, cash-based services directly to patients.

Stronger revenue potential will allow clinics to confidently adopt innovative therapeutic technologies, helping to improve quality of care nationwide.

“We understand the concerns private practice owners face in today’s market,” said Carl Mattiola, CEO of Breakthrough. “Our goal is to help practices educate patients directly so they can make informed decisions about their health; our software makes that marketing work as streamlined as possible for busy clinicians. We’re thrilled to add exclusive Enovis™ campaigns to our library of marketing solutions. This will help an immense number of patients gain access to therapies they wouldn’t experience otherwise.”

“As a leading medical technology company, Enovis™ is focused on developing innovative solutions that generate better patient outcomes. Part of our mission is to help healthcare professionals thrive, and we are thrilled about what this partnership with Breakthrough means for our customers and their businesses,” said Guy Guglielmino, President of Enovis™ Recovery Sciences.

Enovis™ and Breakthrough developed this exclusive partnership to support private practice and clinic owners in conservative healthcare, enhance patient engagement, and drive the adoption of innovative, clinically differentiated therapeutic technologies.

“Combining innovative cash-based services with tailored marketing campaigns is a win-win: private practices can help improve patient outcomes, and this partnership gives clinics the tools they need to thrive despite current economic challenges,” said Chad Madden, Co-Founder of Breakthrough. 

Many insurance companies do not reimburse for treatments made possible by modern medical technologies, such as laser therapy. Patients are often unaware of these affordable self-pay rehabilitative options.

Through education-focused marketing campaigns, private practice clinicians can promote cash-pay therapeutic services and increase their profit margins despite declining reimbursements.

Private practice owners and conservative care clinicians could experience strong revenue growth when investing in LightForce^Ⓡ Laser Therapy, Radial Pressure Wave Therapy, and Traction Therapy from Chattanooga^Ⓡ, as well as other therapeutic modalities from Enovis™ Corporation. 

“Breakthrough’s system is really helpful for getting patients in the door & getting the word out about our LightForce^Ⓡ Laser cash services,” says Tony Cere, owner of Kinetix PT in Gainesville, FL. “To make a big investment like that, you’ve got to know you can bring in the income. With Breakthrough, we didn’t have to worry.”

Clinicians will be better able to engage potential patients directly, drive awareness of affordable cash-based treatment options, secure better profit margins, and help positively impact patient outcomes.

For more information about the new partnership, visit https://getbreakthrough.com/enovis

Contact Information:

Andrea Sanders

Senior Marketing Manager

[email protected]

Original Source:

Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability

The post Breakthrough and Enovis (TM) Announce Official Partnership, Empowering Private Practice Healthcare to Help Improve Quality of Care While Increasing Profitability appeared first on AESTHETIC NEWS.

Owkin-Logo Logo Owkin

PARIS, France, September 11, 2023 (Newswire.com)
–
Owkin and Tribun Health announce a strategic partnership to advance the devel…

The post Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research appeared first on AESTHETIC NEWS.

New Educational Materials Provide Important Data on Polio and the Polio Vaccine

NEWPORT BEACH, Calif., September 7, 2023 (Newswire.com)
–
Physicians for Informed Consent (PIC) has introduced two new educational documents, “Polio: What Parents Need to Know” and “IPV Vaccine: Is It Safer Than Polio?” Packed with key statistical data on the risk of polio as well as the risk of the IPV (inactivated poliovirus) vaccine, the documents assist parents in making a more informed risk-benefit calculation for vaccination. 

“Now more than ever, people have concerns about vaccines on the childhood vaccination schedule, and a question we hear all the time is ‘What about polio?'” said Greg Glaser, general counsel and national coalition director for Physicians for Informed Consent. “These new documents scientifically address this question, so more parents can research the vaccine and decide what’s best for their children.” 

The following is a summary of essential facts included in the documents.

Polio – Disease Information Statement (DIS):

• About 95% of people who contract polio have no symptoms (asymptomatic).
• The great majority of polio infections that are fatal or result in permanent paralysis occur in people who have had their tonsils surgically removed (tonsillectomy) or do not rest after feeling sick. 
• Before the introduction of the polio vaccine in 1955, paralytic poliomyelitis was a disease of low incidence, occurring in about 1 in 22,000 or 0.005% in the U.S. population. 
• Before the polio vaccine was introduced, about 0.0005% (1 in 190,000) of children at normal risk contracted polio that was fatal or led to permanent paralysis.

Polio  – Vaccine Risk Statement (VRS):

• The polio vaccine does not prevent asymptomatic infection or transmission.
• The Institute of Medicine has not ruled out the possibility that IPV vaccination can lead to Guillain-Barré syndrome or sudden infant death syndrome (SIDS).
• Seizures may occur in about 1 in 829 children vaccinated with IPV vaccine.
• A study published in the Journal of the American Medical Association (JAMA) shows an IPV-containing vaccine may cause permanent injury 38 times more often than permanent injury from polio infection.
• The polio vaccine has not been proven safer than polio infection for normal-risk children.

“As polio is so feared in our culture, the data we reveal is paradigm-shifting,” said Dr. Shira Miller, founder and president of Physicians for Informed Consent. “Our educational documents show that for normal-risk children the polio vaccine is not proven safer than polio infection — which has serious implications for both children’s health and vaccine mandates for school attendance.”

To protect and enhance children’s health, it’s necessary that parents have access to reliable infectious disease and vaccine educational information. PIC makes scientific data freely available through its education program, a growing collection of concise, reader-friendly educational materials that support parents, physicians, and policymakers in calculating the risk-benefit ratio of vaccination. To read the newest DIS and VRS documents on polio and the IPV vaccine, visit physiciansforinformedconsent.org/polio.

Contact Information:

Greg Glaser

General Counsel

[email protected]

925-642-6651

Original Source:

Physicians for Informed Consent States, ‘For Normal-Risk Children, the Polio Vaccine is Not Proven Safer Than Polio Infection’

The post Physicians for Informed Consent States, ‘For Normal-Risk Children, the Polio Vaccine is Not Proven Safer Than Polio Infection’ appeared first on AESTHETIC NEWS.

Uncover Mental Health Counseling, founded by Kristie Tse, stands as a leading mental health practice in NYC that prioritizes inclusivity, cultural sensitivity, and personal growth through evidence-based treatments. The…

The post Uncover Mental Health Counseling Marks 4 Years of Transformative Impact appeared first on AESTHETIC NEWS.

READING, Pa., September 5, 2023 (Newswire.com)
–
Dr. Stephen Banco, a nationally recognized orthopedic spine surgeon, has achieved a groundbreaking milestone with the successful completion of the first-in-man spine surgery utilizing the innovative Waypoint GPS™ smart pedicle probe. This remarkable achievement marks a significant advancement in spinal surgery techniques, promising enhanced precision and patient outcomes.

The Waypoint GPS system, developed by Waypoint Orthopedics, Inc., intends to create a paradigm shift in spinal surgical navigation. By combining state-of-the-art visualization technology with standard instrumentation, the system aims to provide surgeons with increased accuracy and confidence during their cases. Dr. Banco’s successful utilization of the technology underscores its potential to revolutionize the field of spine surgery.

During the surgery, Dr. Banco utilized the Waypoint GPS system to navigate the cannulation of 10 pedicles in a 5-level PLF. The system allowed Dr. Banco to identify optimal paths for his pedicle screws prior to tapping and execute the procedure with an unprecedented level of confidence without the use of fluoroscopic guidance. The real-time feedback provided by the system allowed Dr. Banco to carefully monitor and adjust every movement, ultimately leading to a 100% accuracy in screw placement, with zero pedicle breaches, as confirmed by x-ray and neuromonitoring. 

“I am truly excited about the potential of the Waypoint GPS system,” said Dr. Banco. “This technology has the capacity to redefine how we approach spine surgeries. Its accuracy and real-time feedback empower surgeons to make informed decisions during procedures, resulting in better patient outcomes and reduced recovery times.”

The successful outcome of this pioneering surgery highlights the collaborative effort between Dr. Banco and the dedicated team at Waypoint Orthopedics, who have tirelessly worked to develop and refine the Waypoint GPS system. The achievement sets a new standard for precision in spine surgery in any surgical setting. 

“We are immensely proud of Dr. Banco’s accomplishment and the successful integration of our Waypoint GPS technology into clinical practice,” stated Jeffrey F. O’Donnell, Jr., President and CEO of Waypoint Orthopedics. “This achievement is a testament to our commitment to innovation and improving patient care. We look forward to witnessing the continued impact of this technology on the lives of countless patients.”

Waypoint Orthopedics is the first portfolio company of Runway Healthcare, LP, a MedTech accelerator fund. Runway Healthcare builds commercially ready opportunities for the medical device industry to acquire following regulatory approval. 

The Waypoint GPS™ is FDA-cleared and indicated for use during pedicle screw pilot hole drilling to provide visual feedback to the surgeon of changes in color to the tissue at the tip of the probe that may indicate contact with soft tissues and possible vertebral cortex perforation. The Waypoint GPS is indicated for use in both open and percutaneous (MIS) procedures.

About Waypoint Orthopedics:

Waypoint Orthopedics, Inc. was founded to make vertebral fixation safer and more efficient for the patient, surgeon, and support staff. Waypoint Orthopedics’ product, the Waypoint GPS, uses proprietary color-sensing technology to inform the operator of the bone/tissue type change at the cutting edge of the awl. Waypoint Orthopedics’ controlling stockholder is Runway Healthcare, LP – a MedTech accelerator fund.

Inquiries: 

[email protected]

www.WaypointOrthopedics.com 

About Runway Healthcare, LP:

Runway Healthcare, LP is an early-stage MedTech accelerator. Runway Healthcare finances and manages the product development process of its portfolio companies. After navigating a portfolio company through the regulatory process, Runway Healthcare seeks to transition the portfolio company’s ownership to a larger multi-national healthcare company for commercialization. Runway Healthcare is focused on early-stage technology in the Orthopedic, Cardiovascular, and Neurology sectors.

Inquiries:

[email protected] 

www.RunwayHC.com 

Forward-Looking Statements:

This press release contains “forward-looking statements” concerning the development of Waypoint Orthopedics products, the potential benefits and attributes of those products, and the company’s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions, and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Waypoint Orthopedics undertakes no obligation to update any forward-looking statements for any reason.

Contact Information:

Jeff O’Donnell

President & CEO

[email protected]

Original Source:

Milestone Achievement: Waypoint GPS Assists Dr. Stephen Banco in Groundbreaking First-in-Man Spine Surgery

The post Milestone Achievement: Waypoint GPS Assists Dr. Stephen Banco in Groundbreaking First-in-Man Spine Surgery appeared first on AESTHETIC NEWS.